BEUDAMED
    8,284 results · 8ms · Sources: EU EUDAMED, US FDA

    Get notified when this changes

    We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.
    Filters FDA Pre Market Approval × Classification: FDA Class 3 × Clear all

    Test System, For Drugs Of Abuse

    FDA Pre-Market Approval
    FDA Class 3 ·AWARE TEST SYSTEM

    Osseoanchored Prostheses For The Rehabilitation Of Transfemoral Amputees

    FDA Pre-Market Approval
    FDA Class 3 ·OPRA Implant System

    Transdermal Test For Assessment Of Glomerular Filtration Rate

    FDA Pre-Market Approval
    FDA Class 3 ·MediBeacon® Transdermal GFR Measurement System (TGFR)

    Osseoanchored Prostheses For The Rehabilitation Of Transfemoral Amputees

    FDA Pre-Market Approval
    FDA Class 3 ·OPRA Implant System

    Transdermal Test For Assessment Of Glomerular Filtration Rate

    FDA Pre-Market Approval
    FDA Class 3 ·MediBeacon® Transdermal GFR Measurement System (GFR)

    Osseoanchored Prostheses For The Rehabilitation Of Transfemoral Amputees

    FDA Pre-Market Approval
    FDA Class 3 ·OPRA Implant System

    Osseoanchored Prostheses For The Rehabilitation Of Transfemoral Amputees

    FDA Pre-Market Approval
    FDA Class 3 ·OPRA™ Implant System

    Osseoanchored Prostheses For The Rehabilitation Of Transfemoral Amputees

    FDA Pre-Market Approval
    FDA Class 3 ·OPRA Implant System

    Transdermal Test For Assessment Of Glomerular Filtration Rate

    FDA Pre-Market Approval
    FDA Class 3 ·MediBeacon® Transdermal GFR Measurement System (TGFR)

    Osseoanchored Prostheses For The Rehabilitation Of Transfemoral Amputees

    FDA Pre-Market Approval
    FDA Class 3 ·OPRA Implant System

    Osseoanchored Prostheses For The Rehabilitation Of Transfemoral Amputees

    FDA Pre-Market Approval
    FDA Class 3 ·OPRA System

    Deep Brain Stimulation For The Treatment Of Dystonia

    FDA Pre-Market Approval
    FDA Class 3 ·Medtronic DBS Therapy for Dystonia

    Transdermal Test For Assessment Of Glomerular Filtration Rate

    FDA Pre-Market Approval
    FDA Class 3 ·MediBeacon® Transdermal GFR Measurement System (TGFR)

    Osseoanchored Prostheses For The Rehabilitation Of Transfemoral Amputees

    FDA Pre-Market Approval
    FDA Class 3 ·OPRA Implant System

    Osseoanchored Prostheses For The Rehabilitation Of Transfemoral Amputees

    FDA Pre-Market Approval
    FDA Class 3 ·OPRA Implant System

    Osseoanchored Prostheses For The Rehabilitation Of Transfemoral Amputees

    FDA Pre-Market Approval
    FDA Class 3 ·OPRA Implant System, Abutment component

    Osseoanchored Prostheses For The Rehabilitation Of Transfemoral Amputees

    FDA Pre-Market Approval
    FDA Class 3 ·OPRA™ System

    Osseoanchored Prostheses For The Rehabilitation Of Transfemoral Amputees

    FDA Pre-Market Approval
    FDA Class 3 ·OPRA™ Implant System

    Catheter, Percutaneous, Cardiac Ablation, For Treatment Of Atrial Flutter

    FDA Pre-Market Approval
    FDA Class 3 ·Blazer Open-Irrigated Ablation Catheter

    Implanted Electrical Device Intended For Treatment Of Fecal Incontinence

    FDA Pre-Market Approval
    FDA Class 3 ·Interstim Therapy System, Verify Evaluation System (SNS) Bowel